The Past, Present, and Future of Nicotine Addiction Therapy.

The tobacco addiction treatment field is progressing through innovations in medication development, a focus on precision medicine, and application of new technologies for delivering support in real time and over time. This article reviews the evidence for combined and extended cessation pharmacotherapy and behavioral strategies including provider advice, individual counseling, group programs, the national quitline, websites and social media, and incentives. Healthcare policies are changing to offer cessation treatment to the broad population of smokers. With knowledge of the past and present, this review anticipates what is likely on the horizon in the clinical and public health effort to address tobacco addiction.

[1]  Tim Lancaster,et al.  Individual behavioural counselling for smoking cessation. , 2017, The Cochrane database of systematic reviews.

[2]  Maeve Duggan,et al.  Social Media Update 2016 , 2016 .

[3]  Ron Borland,et al.  Electronic Nicotine Delivery System , 2015 .

[4]  Brian A. King,et al.  Current Cigarette Smoking Among Adults — United States, 2016 , 2015, MMWR. Morbidity and mortality weekly report.

[5]  R. Courtney,et al.  The Health Consequences of Smoking-50 Years of Progress: A Report of the Surgeon General, 2014Us Department of Health and Human Services Atlanta, GA: Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for: Critique , 2015 .

[6]  D. Schroeder,et al.  Depressive symptoms among patients receiving varenicline and bupropion for smoking cessation. , 2015, Journal of substance abuse treatment.

[7]  R. West,et al.  Is the use of electronic cigarettes while smoking associated with smoking cessation attempts, cessation and reduced cigarette consumption? A survey with a 1‐year follow‐up , 2015, Addiction.

[8]  Jamie Brown,et al.  Associations Between E-Cigarette Type, Frequency of Use, and Quitting Smoking: Findings From a Longitudinal Online Panel Survey in Great Britain , 2015, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[9]  Brian A. King,et al.  Tobacco Use Among Middle and High School Students — United States, 2011–2014 , 2015, MMWR. Morbidity and mortality weekly report.

[10]  B. Hitsman,et al.  Long-term nicotine replacement therapy: a randomized clinical trial. , 2015, JAMA internal medicine.

[11]  Judith J Prochaska,et al.  A Mixed-Methods Study of Young Adults' Receptivity to Using Facebook for Smoking Cessation: If You Build It, Will They Come? , 2015, American journal of health promotion : AJHP.

[12]  S. Rennard,et al.  Effect of varenicline on smoking cessation through smoking reduction: a randomized clinical trial. , 2015, JAMA.

[13]  Cynthia M. Lakon,et al.  Development of a Twitter-Based Intervention for Smoking Cessation that Encourages High-Quality Social Media Interactions via Automessages , 2015, Journal of medical Internet research.

[14]  L. Hawk,et al.  Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial. , 2015, The Lancet. Respiratory medicine.

[15]  Rebecca Knight,et al.  Risk Factors for Exclusive E-Cigarette Use and Dual E-Cigarette Use and Tobacco Use in Adolescents , 2015, Pediatrics.

[16]  Joan L Bottorff,et al.  Picture Me Smokefree: A Qualitative Study Using Social Media and Digital Photography to Engage Young Adults in Tobacco Reduction and Cessation , 2015, Journal of medical Internet research.

[17]  Hayden McRobbie,et al.  Cytisine versus nicotine for smoking cessation. , 2014, The New England journal of medicine.

[18]  Brian A. King,et al.  Current Cigarette Smoking Among Adults — United States, 2005–2013 , 2014, MMWR. Morbidity and mortality weekly report.

[19]  T. Baker,et al.  Five population-based interventions for smoking cessation: a MOST trial , 2014, Translational behavioral medicine.

[20]  E. Bateman,et al.  Efficacy of varenicline combined with nicotine replacement therapy vs varenicline alone for smoking cessation: a randomized clinical trial. , 2014, JAMA.

[21]  S. Shiffman,et al.  Addressing the evidence for FDA nicotine replacement therapy label changes: a policy statement of the Association for the Treatment of Tobacco use and Dependence and the Society for Research on Nicotine and Tobacco. , 2014, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[22]  Suchitra Krishnan-Sarin,et al.  Text messaging-based smoking cessation intervention: a narrative review. , 2014, Addictive behaviors.

[23]  Shu-Hong Zhu,et al.  Prevalence and correlates of quitline awareness and utilization in the United States: an update from the 2009-2010 National Adult Tobacco Survey. , 2014, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[24]  Brian A. King,et al.  Current Cigarette Smoking Among Adults — United States, 2005–2012 , 2014, MMWR. Morbidity and mortality weekly report.

[25]  D. Schroeder,et al.  Combination varenicline and bupropion SR for tobacco-dependence treatment in cigarette smokers: a randomized trial. , 2014, JAMA.

[26]  Gladys N. Pachas,et al.  Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: a randomized clinical trial. , 2014, JAMA.

[27]  E Paul Wileyto,et al.  Diffusion of an evidence-based smoking cessation intervention through Facebook: a randomised controlled trial study protocol , 2014, BMJ Open.

[28]  Hayden McRobbie,et al.  Electronic cigarettes for smoking cessation: a randomised controlled trial , 2013, The Lancet.

[29]  F. Windmeijer,et al.  Smoking cessation treatment and risk of depression, suicide, and self harm in the Clinical Practice Research Datalink: prospective cohort study , 2013, BMJ.

[30]  C. Yunis,et al.  Effects of Varenicline on Smoking Cessation in Adults With Stably Treated Current or Past Major Depression , 2013, Annals of Internal Medicine.

[31]  Brian A. King,et al.  Awareness and ever-use of electronic cigarettes among U.S. adults, 2010-2011. , 2013, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[32]  H. Svanström,et al.  Use of varenicline versus bupropion and risk of psychiatric adverse events. , 2013, Addiction.

[33]  M. Caruso,et al.  EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as Tobacco Cigarettes Substitute: A Prospective 12-Month Randomized Control Design Study , 2013, PloS one.

[34]  S. Chapman.  Should electronic cigarettes be as freely available as tobacco cigarettes? No , 2013, BMJ.

[35]  J. Etter.  Should electronic cigarettes be as freely available as tobacco? Yes , 2013, BMJ.

[36]  R. Perera,et al.  Pharmacological interventions for smoking cessation: an overview and network meta-analysis. , 2013, The Cochrane database of systematic reviews.

[37]  Katie Myers Smith,et al.  Is a combination of varenicline and nicotine patch more effective in helping smokers quit than varenicline alone? A randomised controlled trial , 2013, BMC Medicine.

[38]  A. McNeill,et al.  E-Cigarettes: Prevalence and Attitudes in Great Britain , 2013, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[39]  Jeffrey M. Engelmann,et al.  Effects of varenicline and bupropion sustained-release use plus intensive smoking cessation counseling on prolonged abstinence from smoking and on depression, negative affect, and other symptoms of nicotine withdrawal. , 2013, JAMA psychiatry.

[40]  Jessica L. Burris,et al.  Clinical Strategies to Enhance the Efficacy of Nicotine Replacement Therapy for Smoking Cessation: A Review of the Literature , 2013, Drugs.

[41]  Andrzej Sobczak,et al.  Levels of selected carcinogens and toxicants in vapour from electronic cigarettes , 2013, Tobacco Control.

[42]  M. Goniewicz,et al.  Patterns of electronic cigarette use and user beliefs about their safety and benefits: an internet survey. , 2013, Drug and alcohol review.

[43]  H. McRobbie,et al.  Efficacy of cytisine in helping smokers quit: systematic review and meta-analysis , 2013, Thorax.

[44]  Nicola Lindson-Hawley,et al.  Reduction versus abrupt cessation in smokers who want to quit. , 2012, The Cochrane database of systematic reviews.

[45]  J. Thompson,et al.  A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder. , 2012, The Journal of clinical psychiatry.

[46]  J. Prochaska,et al.  Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysis , 2012, BMJ : British Medical Journal.

[47]  L. Ku,et al.  The Return on Investment of a Medicaid Tobacco Cessation Program in Massachusetts , 2012, PloS one.

[48]  S. Glantz,et al.  Cardiology Rx for Change: Improving Clinical Attention to Tobacco Use and Secondhand Smoke Exposure in Cardiology , 2011, Clinical cardiology.

[49]  Kenneth W Lin,et al.  Nicotine receptor partial agonists for smoking cessation. , 2011, American family physician.

[50]  C. Furberg,et al.  Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis , 2011, Canadian Medical Association Journal.

[51]  Kevin G Volpp,et al.  Redesigning employee health incentives--lessons from behavioral economics. , 2011, The New England journal of medicine.

[52]  James M. Leonhardt,et al.  Twitter=quitter? An analysis of Twitter quit smoking social networks , 2011, Tobacco Control.

[53]  M. Kenward,et al.  Smoking cessation support delivered via mobile phone text messaging (txt2stop): a single-blind, randomised trial , 2011, The Lancet.

[54]  R. Whittaker,et al.  Pre-cessation nicotine replacement therapy: pragmatic randomized trial. , 2010, Addiction.

[55]  E. Gilpin,et al.  The effect of smoke-free homes on adult smoking behavior: a review. , 2009, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[56]  S. Hall,et al.  Extended treatment of older cigarette smokers. , 2009, Addiction.

[57]  S. Hall,et al.  Treatment of smokers with co-occurring disorders: emphasis on integration in mental health and addiction treatment settings. , 2009, Annual review of clinical psychology.

[58]  Kevin G Volpp,et al.  A randomized, controlled trial of financial incentives for smoking cessation. , 2009, The New England journal of medicine.

[59]  N. Benowitz.  Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. , 2009, Annual review of pharmacology and toxicology.

[60]  Jessie E Saul,et al.  Utilization of Smoking Cessation Informational, Interactive, and Online Community Resources as Predictors of Abstinence: Cohort Study , 2008, Journal of medical Internet research.

[61]  Richard P Moser,et al.  Effect of Adding a Virtual Community (Bulletin Board) to Smokefree.gov: Randomized Controlled Trial , 2008, Journal of medical Internet research.

[62]  S. Hall,et al.  Evaluation of an Evidence-Based Tobacco Treatment Curriculum for Psychiatry Residency Training Programs , 2008, Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry.

[63]  M. Goolsby,et al.  Treating Tobacco Use and Dependence , 2008, Pediatrics.

[64]  Tobacco Use and Dependence Guideline Panel.  Treating Tobacco Use and Dependence: 2008 Update , 2008 .

[65]  S. Shiffman,et al.  Nicotine patch therapy prior to quitting smoking: a meta-analysis. , 2008, Addiction.

[66]  R. West,et al.  Randomized controlled trial of a social support ('buddy') intervention for smoking cessation. , 2006, Patient education and counseling.

[67]  Brian G Danaher,et al.  Defining Participant Exposure Measures in Web-Based Health Behavior Change Programs , 2006, Journal of medical Internet research.

[68]  S. Tonstad,et al.  Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial. , 2006, JAMA.

[69]  David Gonzales,et al.  Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Sustained-Release Bupropion and Placebo for Smoking Cessation: A Randomized Controlled Trial , 2006 .

[70]  Maria A Oquendo,et al.  Prospective study of clinical predictors of suicidal acts after a major depressive episode in patients with major depressive disorder or bipolar disorder. , 2004, The American journal of psychiatry.

[71]  J. Cryan,et al.  Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat , 2003, Psychopharmacology.

[72]  D. Jorenby,et al.  Treating tobacco use and dependence: an evidence-based clinical practice guideline for tobacco cessation. , 2002, Chest.

[73]  A. Buist,et al.  Sustained-Release Bupropion for Pharmacologic Relapse Prevention after Smoking Cessation , 2001, Annals of Internal Medicine.

[74]  S. May,et al.  Do social support interventions (“buddy systems”) aid smoking cessation? A review , 2000, Tobacco control.

[75]  M. Damaj,et al.  Bupropion is a nicotinic antagonist. , 2000, The Journal of pharmacology and experimental therapeutics.

[76]  T. Lancaster,et al.  Training health professionals in smoking cessation. , 2000, The Cochrane database of systematic reviews.

[77]  J. Andrews,et al.  Evaluating two self-help interventions for smokeless tobacco cessation. , 2000, Addictive behaviors.

[78]  R. West,et al.  Randomized comparative trial of nicotine polacrilex, a transdermal patch, nasal spray, and an inhaler. , 1999, Archives of internal medicine.

[79]  R. West,et al.  A randomized controlled trial of a "buddy" systems to improve success at giving up smoking in general practice. , 1998, Addiction.

[80]  N. Benowitz,et al.  Is Clonidine an Effective Smoking Cessation Therapy? , 1995, Drugs.

[81]  D. Shalala.  Reducing tobacco use. , 2015, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[82]  James F. Thrasher,et al.  Electronic nicotine delivery systems: international tobacco control four-country survey. , 2013, American journal of preventive medicine.

[83]  Aziz Sheikh,et al.  Internet-based interventions for smoking cessation. , 2013, The Cochrane database of systematic reviews.

[84]  J. Hughes,et al.  Reduction versus abrupt cessation in smokers who want to quit. , 2010, The Cochrane database of systematic reviews.

[85]  L. Tanoue,et al.  A Clinical Blueprint to Accelerate the Elimination of Tobacco Use , 2009 .

[86]  D. Mant,et al.  Nicotine replacement therapy for smoking cessation. , 2008, The Cochrane database of systematic reviews.

[87]  S. Rennard,et al.  Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. , 2006, JAMA.

[88]  R Perera,et al.  Competitions and incentives for smoking cessation. , 2005, The Cochrane database of systematic reviews.

[89]  L. Stead,et al.  Physician advice for smoking cessation. , 2004, The Cochrane database of systematic reviews.

[90]  R. Perera,et al.  Telephone counselling for smoking cessation. , 2003, The Cochrane database of systematic reviews.

[91]  J. Mackay,et al.  The Tobacco Atlas , 2002 .

[92]  B. Mehić.  [Nicotine addiction]. , 2001, Medicinski arhiv.

[93]  L. Stead,et al.  Group behaviour therapy programmes for smoking cessation. , 2000, The Cochrane database of systematic reviews.

[94]  D. Schroeder,et al.  A comparison of sustained-release bupropion and placebo for smoking cessation. , 1997, The New England journal of medicine.